Prolactin and growth hormone responses to hypoglycemia in patients with systemic sclerosis and psoriatic arthritis

Ann N Y Acad Sci. 2006 Jun:1069:145-8. doi: 10.1196/annals.1351.012.

Abstract

This study compared prolactin (PRL) and growth hormone (GH) responses to hypoglycemia in premenopausal females with systemic sclerosis (SSc) and psoriatic arthritis (PsA) with those in matched healthy controls. No differences were found in glucose and GH responses to hypoglycemia in both groups of patients compared to controls. SSc patients had lower PRL response (P < 0.05) to hypoglycemia compared to controls. PRL response tended to be lower also in PsA patients, however the difference did not reach level of statistical significance (P = 0.11). The present study showed decreased PRL response to hypoglycemia in premenopausal females with SSc.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / metabolism
  • Blood Glucose / metabolism
  • Female
  • Growth Hormone / blood
  • Growth Hormone / therapeutic use*
  • Humans
  • Hypoglycemia / complications
  • Hypoglycemia / drug therapy*
  • Hypoglycemia / metabolism
  • Prolactin / blood
  • Prolactin / therapeutic use*
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / metabolism

Substances

  • Blood Glucose
  • Prolactin
  • Growth Hormone